Bicycle Therapeutics BCYC
NASDAQ BCYC
$4.28 +0.04 (+0.97%)
As of: Sep 4, 2026 · 12:52 PM EDT

Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026)

Bicycle Therapeutics' (BCYC) quarterly Other Non Operating Income came in at $69000.0 in Q2 2026, down 90.74% YoY from $745000.0 in Q2 2025, and down 35.51% on a QoQ basis from $107000.0 in Q1 2026.

Analysis

Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026) Analysis & Trends

Bicycle Therapeutics (BCYC) has 5 years of Other Non Operating Income data on file, last reported at $69000.0 in Q2 2026.

  • Quarterly Other Non Operating Income fell 90.74% year-over-year to $69000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.5 million (up 3078.63% YoY) and the FY2025 annual result came in at $13.9 million, up 1489.3% from the prior year.
  • Other Non Operating Income slipped to $69000.0 in Q2 2026, from $107000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $13.2 million in Q4 2025 to a low of -$1.0 million in Q3 2024.
  • A 3-year average of $1.5 million and a median of $101000.0 in 2024 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 637.62% in 2025, down 380.28% in 2025.
  • Tracing BCYC's Other Non Operating Income over 3 years: stood at -$1.0 million in 2024, then surged by 1418.9% to $13.2 million in 2025, then slumped by 99.48% to $69000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $69000.0 (Q2 2026), $107000.0 (Q1 2026), and $13.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Bicycle Therapeutics 299.11 Mn 299.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69,000.00
Mar 31, 2026 107,000.00
Dec 31, 2025 13.19 Mn
Sep 30, 2025 158,000.00
Jun 30, 2025 745,000.00
Mar 31, 2025 -199,000.00
Sep 30, 2024 -1.00 Mn
Jun 30, 2024 101,000.00
Mar 31, 2024 71,000.00
Jun 30, 2019 -2.18 Mn
Mar 31, 2019 -3.19 Mn
Dec 31, 2018 807,000.00
Sep 30, 2018 -1.36 Mn
Jun 30, 2018 -73,000.00